Sproxil

Sproxil

Sproxil is combating the global counterfeit drug ...

Other | United States of America |

 

Overview

Sproxil is combating the global counterfeit drug market through a Mobile Product Authentication™ (MPA™) solution that enables consumers to verify the authenticity of pharmaceutical products. Sproxil’s MPA solution allows customers to send a free text message containing a code found on a drug to Sproxil’s servers, which immediately respond and indicate whether the drug is genuine or fake. Sproxil has set up Africa’s first national mobile-based anti-counterfeit service in Nigeria, and Acumen Fund’s investment will enable the company to expand into Kenya and India.

Industry

Legal Structure

Operating Status

Employees

Other Operating

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

US Headquarter


Boston, Massachusetts US



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Twitter

Tweet from Sproxil, Inc: @Habiba_Orion @swankpharm Hello, that isn't Sproxil's authentication code. We hope you get a response soon. Posted Thu Jul 20 11:20 am

Tweet from plusacumen: RT @plusacumen: CEO of @Acumen investee @sproxil featured by @Entrepreneur as 1 of 11 African CEOs changing the business landscape https:… Posted Tue Jul 18 5:39 am

Tweet from Duke SEAD: RT @DukeSEAD: Counterfeit pharma is a big issue in #WestAfrica. SEAD's @sproxil is working towards safer medical supply chain: https://t.co… Posted Tue Jul 18 5:39 am

Tweet from Sproxil, Inc: We're hiring a part-time CFO. Tell a friend to tell a friend: thttp://ow.ly/EbTQ30dBlHi Posted Thu Jul 13 2:00 pm

Tweet from Sproxil, Inc: Sproxil in the news. Launch of of Mali operations covered by major media outlets: https://t.co/g6K7HxJGxO Posted Thu Jul 13 1:10 pm

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.